ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
-0.01%
Bitcoin
67,743.26
0.39%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) News

NEO

NeoGenomics (NEO)

NeoGenomics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NEO
DateTimeSourceHeadlineSymbolCompany
05/28/20247:05AMBusiness WireNeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment ManagementNASDAQ:NEONeoGenomics Inc
05/24/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
05/17/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
05/14/20248:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
05/14/20248:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
05/14/20248:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
05/14/20248:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
05/14/20248:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/30/20246:30AMBusiness WireNeoGenomics Reports First Quarter 2024 ResultsNASDAQ:NEONeoGenomics Inc
04/18/20246:05AMBusiness WireNeoGenomics Announces Senior Leadership PromotionsNASDAQ:NEONeoGenomics Inc
04/09/20246:00AMBusiness WireNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NEONeoGenomics Inc
03/27/20247:30AMBusiness WireNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingNASDAQ:NEONeoGenomics Inc
03/20/20246:00AMBusiness WireNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportNASDAQ:NEONeoGenomics Inc
03/06/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
03/04/20244:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
03/01/20246:05AMBusiness WireNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:NEONeoGenomics Inc
02/27/20243:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
02/27/20243:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
02/27/20243:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
02/27/20243:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
02/26/20243:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NEONeoGenomics Inc
02/20/20243:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
02/20/20243:23PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NEONeoGenomics Inc
02/20/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
02/20/20243:05PMBusiness WireNeoGenomics Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:NEONeoGenomics Inc
02/20/20244:37AMIH Market NewsMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices DipNASDAQ:NEONeoGenomics Inc
02/15/20243:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
02/14/20249:04AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NEONeoGenomics Inc
02/09/20242:17PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NEONeoGenomics Inc
02/01/20246:05AMBusiness WireNeoGenomics Signs Working with Cancer Pledge in Support of EmployeesNASDAQ:NEONeoGenomics Inc
 Showing the most relevant articles for your search:NASDAQ:NEO

Your Recent History

ASX
MICH
Magellan Infrastructure
BIT
P1YZU6
NLBNPIT1YZU6 20991231 28...
ASX
TLSKOQ
BOV
SRNA3R
Serena Energia ON
KOSPI
74701B8A
No 229 Class A UIT
BOV
JSAF12
Js Ativos Financeiros Fu...
NASDAQ
FPARX
Future Path 529 College ...
NASDAQ
WCASX
WCM China AShares Growth...
UNSW3
INSUREETH
InsureToken
LSE
PA.
NASDAQ
FFBOMX
Technology Select Portfo...
EU
CDCML
Caisse des Dpts et Consi...
COIN
CUZBTC
CUZ
EU
BEC0000BIE81
Crelan SA Floating Rate ...
HUOB
NEWBTC
Newton
EU
CADFC
CADES Caisse Amort Dette...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved